Global Cell RNA Detection Market 2018-2022 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 9, 2018--The “Global Cell RNA Detection Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.
The Global Cell RNA Detection Market to grow at a CAGR of 5.76% during the period 2018-2022.
Global Cell RNA Detection Market 2018-2022 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Growing opportunities in developing nations are one of the major trends in the market. Emerging economies provide huge growth opportunities due to extensive government support and significant R&D investments by the leading vendors.
According to the report, one driver influencing this market is the increased demand for cell RNA detection in biotechnology. Cell RNA detection is generally used for clinical purposes. However, cell RNA detection is gaining traction in the biotechnology sector for various purposes such as cell engineering, protein engineering, and physiological research.
Further, the report states that one challenge affecting this market is the high costs associated with cell-based research. At times, researchers also misidentify cell lines and use contaminated cells for experiments. Such experiments generate incorrect results, which increases the cost associated with the particular study.
Key vendorsAgilent Technologies Merck KGaA Promega QIAGEN Thermo Fisher Scientific
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 05: MARKET SIZINGMarket definition Market sizing 2017 Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSISBargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USERComparison by end-user Pharmaceutical and biotechnology companies Research and academic institutes Others Market opportunity by end-user
PART 09: REGIONAL LANDSCAPEGeographical segmentation Regional comparison Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGESMarket drivers Market challenges
PART 12: MARKET TRENDSGrowing opportunities in developing nations Presence of innovative products Growing number of workshops/seminars
PART 13: VENDOR LANDSCAPEOverview Landscape disruption
PART 14: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors
For more information about this report visit https://www.researchandmarkets.com/research/4d99k2/global_cell_rna?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181009005975/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENETICS RESEARCH SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/09/2018 12:52 PM/DISC: 10/09/2018 12:52 PM